A new study led by the University of Melbourne reveals that the antibiotic rifaximin contributes to the rise of vancomycin-resistant enterococcus faecium (VRE) and threatens its treatment with ...

These bacteria have evolved the ability to resist treatment with antibiotics, and it's making them more deadly and harder to ...

One of the global challenges faced by the mankind is the rapid rise of antimicrobial resistance (AMR) among bacterial pathogens. The biggest concern is imposed by the ‘ESKAPE’ pathogens comprising of ...

A study by an international team of researchers suggests that widespread use of an antibiotic to prevent liver disease is causing cross-resistance to a last-resort antibiotic for treating ...

The antibiotic, rifaximin, has enabled the global emergence of vancomycin-resistant enterococcus faecium ... one of the last effective treatment options against VRE infections.

Because of the increasing prevalence of VRE infection and the limited treatment options available ... Vancomycin-resistant enterococci. Julien Ferrari, PhD, and Thomas Rotolo, PhD, of ApotheCom ...

A MAJOR international study has linked rifaximin with the global rise of a multidrug-resistant bacterial pathogen, vancomycin-resistant Enterococcus faecium (VREfm), a high-priority pathogen and ... a ...

has led to the global emergence of an almost untreatable form of the antimicrobial resistant superbug vancomycin-resistant enterococcus faecium (VRE), which frequently causes serious infections in ...